10-Q: Albertsons Reports Mixed Q1 Results Amidst Digital Growth and Ongoing Legal Battles

Albertsons Companies, Inc. reported a 2.5% increase in net sales driven by strong digital and pharmacy growth, but saw declines in net income and adjusted EBITDA, while navigating significant legal challenges including the terminated Kroger merger.

Summary

• Net sales and other revenue increased 2.5% to $24,880.8 million for the 16 weeks ended June 14, 2025, up from $24,265.4 million in the prior year period.
• Identical sales, excluding fuel, increased 2.8%, primarily driven by strong growth in pharmacy sales.
• Digital sales grew by 25% compared to the first quarter of fiscal 2024.
• Loyalty members increased 14% to 47.3 million.
• Net income decreased to $236.4 million ($0.41 per Class A common share) from $240.7 million ($0.41 per Class A common share) in the prior year.
• Adjusted net income was $318.9 million ($0.55 per Class A common share), down from $391.6 million ($0.66 per Class A common share) in the prior year.
• Adjusted EBITDA was $1,111.0 million (4.5% of Net sales), a decrease from $1,183.9 million (4.9% of Net sales) in the prior year.
• Gross margin rate decreased to 27.1% from 27.8%, primarily due to investments in customer value, strong pharmacy sales growth (lower margin), and increased digital delivery costs, partially offset by productivity initiatives.
• Selling and administrative expenses as a percentage of net sales decreased to 25.4% from 25.9%, driven by lower merger-related costs and leveraging of employee and operating expenses from digital/technology modernization.
• Net cash provided by operating activities decreased to $754.4 million from $960.9 million, attributed to lower Adjusted EBITDA, increased cash paid for property taxes and self-insurance, working capital changes, and higher business transformation costs.
• Capital expenditures were approximately $585 million, including 36 remodels and 3 new store openings.
• Repurchased 14.2 million shares of common stock for $314.8 million under a $2.0 billion share repurchase program.
• Paid cash dividends of $85.7 million ($0.15 per common share).
• Refinanced $600.0 million of 7.500% senior unsecured notes due March 15, 2026, with $600.0 million of 6.250% senior unsecured notes due March 15, 2033.

Sentiment

Score: 5

Explanation: The company shows mixed financial results with revenue growth driven by digital and pharmacy, but a decline in profitability metrics (net income, adjusted EBITDA, gross margin rate). Significant ongoing legal challenges, particularly the Kroger merger lawsuit, introduce substantial uncertainty and costs. While the company is actively returning capital to shareholders and investing in strategic growth areas, the legal overhang and profitability decline temper overall sentiment.

Positives

• Net sales and other revenue increased by 2.5% to $24,880.8 million.
• Identical sales, excluding fuel, increased by 2.8%, indicating strong core business performance.
• Digital sales surged by 25%, demonstrating successful investment in online platforms and customer engagement.
• Loyalty membership grew by 14% to 47.3 million, enhancing customer retention and potential future revenue.
• Selling and administrative expenses as a percentage of net sales decreased, reflecting cost management and leveraging of digital and technology investments.
• Successful refinancing of $600.0 million in senior unsecured notes at a lower interest rate (6.250% vs. 7.500%) and extended maturity (2033 vs. 2026).
• Continued capital returns to shareholders through $85.7 million in dividends and $314.8 million in share repurchases.

Negatives

• Net income decreased to $236.4 million from $240.7 million in the prior year period.
• Adjusted net income declined to $318.9 million from $391.6 million.
• Adjusted EBITDA decreased to $1,111.0 million from $1,183.9 million, and its rate as a percentage of net sales also declined.
• Gross margin rate decreased by 70 basis points (85 basis points excluding fuel and LIFO), primarily due to strategic investments in customer value and the higher mix of lower-margin pharmacy sales.
• Net cash provided by operating activities decreased significantly to $754.4 million from $960.9 million, impacted by lower Adjusted EBITDA and changes in working capital.
• Ongoing substantial legal costs and uncertainties related to the terminated Kroger merger, False Claims Act, PBM litigation, and Opioid litigation.

Risks

• Changes in macroeconomic conditions, including food price inflation/deflation, fuel and commodity prices, and international trade uncertainties.
• Shifts in consumer behavior and spending patterns, potentially influenced by changes in state and federal assistance programs.
• Challenges in negotiating acceptable contracts with labor unions and managing wage rates.
• Impact of changes in government regulations on the price and cost of goods.
• Geopolitical environment uncertainties affecting business operations.
• Inability to effectively execute standalone business and value-creating strategies following the termination of the Kroger merger agreement.
• Financial and reputational risks from ongoing litigation related to the terminated Kroger merger, including potential inability to collect the $600 million termination fee.
• Difficulties in recruiting and retaining qualified employees crucial for the 'Customers for Life' strategy.
• Failure to achieve productivity initiatives or implement strategic plans, programs, and partnerships.
• Disruptions and challenges within the supply chain.
• Operational and financial impacts from cyber incidents, including cloud environment outages and effectiveness of business continuity plans.
• Adverse changes in tax rates, tax laws, and regulations.
• Potential liabilities and significant costs arising from various legal proceedings, including False Claims Act, Pharmacy Benefit Manager litigation, and Opioid litigation.
• Environmental liabilities related to waste management, air emissions, underground storage tanks, and contamination clean-up at facilities.

Future Outlook

The company anticipates contributing an additional $13.3 million to its defined pension plans for the remainder of fiscal 2025. Management believes it has significant sources of cash to meet liquidity needs for the next 12 months and the foreseeable future, estimating liquidity needs over this period to be approximately $5.5 billion for working capital, capital expenditures, pension obligations, interest payments, dividends, operating leases, and finance leases. The company is currently evaluating the impact of the recently enacted One Big Beautiful Bill Act on U.S. income tax laws but does not expect it to have a material impact on its financial position or results of operations. The company is also evaluating the impact of new accounting standards (ASU 2023-09 and ASU 2024-03) on its financial statements and disclosures.

Management Comments

• We continued to execute on our Customers for Life strategy, which is centered around driving customer growth and engagement through digital connection, enhancing the customer value proposition, modernizing capabilities through technology and driving productivity.
• We continue to invest in growth through our four digital platforms of eCommerce, Loyalty, Pharmacy & Health and the use of our mobile app in our stores.
• Our focus on delivering an exceptional service experience is fueling new customer acquisition and strengthening existing customer retention.
• We intentionally invested in value, in both loyalty and promotional offerings, as well as by partnering with strategic vendors to invest in price in certain categories and markets.
• We endeavor to use technology in everything we do and over the last few years we have invested strategically to build a best-in-class technology platform, with our core infrastructure in the Cloud and a modernized scalable network.
• Our capital allocation strategy balances investing for the future, strengthening our balance sheet and returns to shareholders through a combination of dividends and opportunistic share repurchases.
• Based on current operating trends, we believe that we have significant sources of cash to meet our liquidity needs for the next 12 months and for the foreseeable future, including cash on hand, cash flows from operating activities and other sources of liquidity, including the ABL Facility.

Industry Context

Albertsons operates in the highly competitive U.S. food retail sector, characterized by thin margins and intense competition from traditional grocers, discounters, and online retailers. The company's focus on digital growth, loyalty programs, and enhancing customer value aligns with broader industry trends of increasing e-commerce penetration and personalized customer experiences. The decline in gross margin rate, partly due to investments in value and the growth of lower-margin pharmacy sales, reflects the industry's pressure to maintain competitive pricing and expand service offerings. The ongoing legal challenges, particularly the terminated Kroger merger, highlight the significant regulatory scrutiny and consolidation pressures within the grocery industry.

Comparison to Industry Standards

• The 2.8% identical sales growth (excluding fuel) is a positive indicator in the grocery sector, which often sees low single-digit comparable sales growth. For context, major competitors like Kroger have reported comparable sales growth (excluding fuel) in a similar range, indicating Albertsons is performing in line with or slightly above some peers in this metric.
• The 25% digital sales growth significantly outpaces the overall industry average for digital adoption, demonstrating strong execution in its e-commerce strategy. This growth rate is comparable to or exceeds the digital growth rates reported by leading grocery chains that have heavily invested in online capabilities.
• The decline in net income and Adjusted EBITDA, while concerning, is partially attributed to strategic investments in customer value and digital platforms, which are common industry responses to competitive pressures and evolving consumer preferences. The impact of these investments on profitability should be assessed against long-term strategic benefits.
• The gross margin rate decrease is consistent with industry trends where grocers are investing in price and loyalty programs to attract and retain customers, often at the expense of short-term margin. The higher mix of pharmacy sales, which typically carry lower gross margins than traditional grocery, also contributes to this trend, similar to other diversified food and drug retailers.
• The company's capital allocation strategy, balancing investments in growth (new stores, remodels, technology) with shareholder returns (dividends, share repurchases), is a standard practice among mature, publicly traded retail companies like Walmart or Target, aiming to optimize long-term value creation.

Legal Proceedings

• False Claims Act (FCA) cases: United States ex rel. Proctor v. Safeway and United States ex rel. Schutte and Yarberry v. SuperValu, New Albertson's, Inc., et al. Both cases allege overcharging federal government healthcare programs by not providing discount benefits. The Supreme Court reversed lower court rulings and remanded both cases. The company prevailed at trial in Schutte (March 12, 2025), but relators filed a motion for a new trial on damages. The Proctor case is scheduled for trial on January 20, 2026. Relators allege damages in excess of $100 million before trebling and penalties.
• Pharmacy Benefit Manager (PBM) Litigation: Health Care Service Corp. et al. v. Albertsons Companies, LLC, et al. (filed January 21, 2021). Challenges prescription-drug prices reported to Prime Therapeutics LLC. The company filed a third-party complaint against Prime. Proceedings are stayed through September 29, 2025, for settlement discussions, with trial scheduled for May 26, 2026.
• Opioid Litigation: The company is a defendant in approximately 81 lawsuits filed by various plaintiffs (states, counties, cities, tribes, hospitals) alleging contribution to the national opioid epidemic. Settled cases in New Mexico and Nevada ($21.5 million paid by insurers). Active state court claims include Dallas County (TX), State of Washington (trial May 4, 2026), and City of Philadelphia (PA, interlocutory appeal heard July 15, 2025). The company has also received subpoenas from the DOJ and state Attorneys General regarding purported violations of the federal Controlled Substances Act and FCA in dispensing prescriptions.
• Termination of the Merger Agreement: The merger agreement with The Kroger Co. was terminated on December 10, 2024, following a preliminary injunction. The company filed a lawsuit against Kroger in Delaware for willful breach of the merger agreement and breach of good faith and fair dealing, seeking damages in addition to the $600 million termination fee. Kroger filed counterclaims. Discovery is ongoing, and trial is scheduled for October 19, 2026.

Stakeholder Impact

• Shareholders: Impacted by financial performance (decreased net income, adjusted EBITDA), capital returns (dividends, share repurchases), and the significant uncertainty and potential financial implications of ongoing legal proceedings, particularly the Kroger merger lawsuit and the False Claims Act cases.
• Employees: Affected by business transformation costs, retention programs related to the terminated merger, and ongoing union negotiations and wage rate changes.
• Customers: Benefit from investments in digital platforms, loyalty programs, and enhanced value propositions, but may be indirectly affected by pricing strategies influenced by competitive pressures and margin management.
• Suppliers: Potential impact from supply chain challenges and the company's productivity initiatives.
• Creditors: Affected by the company's debt management strategies, including refinancing activities, and overall liquidity position, which management believes is adequate.

Next Steps

• Continue execution of the 'Customers for Life' strategy, focusing on digital connection, customer value proposition, technology modernization, and productivity.
• Further investment in digital platforms: eCommerce, Loyalty, Pharmacy & Health, and the mobile app.
• Continued investment in the Albertsons Media Collective to fuel reinvestment into the core business.
• Ongoing evaluation of the impact of the One Big Beautiful Bill Act on U.S. income tax laws.
• Ongoing evaluation of the impact of new accounting standards (ASU 2023-09 and ASU 2024-03) on consolidated financial statements and disclosures.
• Vigorous defense of ongoing legal proceedings, including False Claims Act cases (Proctor trial scheduled for January 20, 2026, Schutte motion for new trial pending), PBM Litigation (stayed for settlement discussions until September 29, 2025, trial scheduled May 26, 2026), and Opioid Litigation (State of Washington trial scheduled May 4, 2026, interlocutory appeals pending for Dallas County and City of Philadelphia).
• Continued engagement in discovery for the lawsuit against Kroger related to the terminated merger, with trial scheduled for October 19, 2026.
• Anticipated contribution of an additional $13.3 million to defined pension plans for the remainder of fiscal 2025.
• Payment of the next quarterly dividend of $0.15 per share on August 8, 2025, to stockholders of record as of July 25, 2025.

Key Dates

Recommendation

Albertsons' Q1 2025 results present a mixed picture: while revenue growth, digital sales, and loyalty member expansion are positive indicators of strategic execution, profitability metrics like net income and Adjusted EBITDA have declined. The company is actively returning capital to shareholders through dividends and share repurchases and has successfully refinanced debt. However, the significant overhang of multiple complex and high-stakes legal proceedings, particularly the lawsuit against Kroger for the $600 million termination fee and the False Claims Act cases, introduces substantial uncertainty and potential financial liabilities. A seasoned investor would likely maintain a 'hold' position, awaiting clearer outcomes on these legal fronts and evidence of sustained profitability improvements, despite the operational strengths in digital and customer engagement.

Keywords

Grocery Retail, Supermarkets, SEC Filing, 10-Q, Financial Results, Albertsons, ACI, Digital Sales, Loyalty Programs, EBITDA, Net Income, Share Repurchase, Dividends, Legal Proceedings, Kroger Merger, False Claims Act, Opioid Litigation, Pharmacy Sales, Customer Engagement, Supply Chain, Corporate Governance